HL: Second-Line Sintilimab Plus Chemo Bests Chemo Alone ...Middle East

News by : (Medscape) -
Use of the PD-1 inhibitor sintilimab in combination with ICE chemotherapy as a second-line treatment in classical Hodgkin lymphoma shows impressive response rates vs chemo alone in the phase 3 ORIENT-21 trial. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( HL: Second-Line Sintilimab Plus Chemo Bests Chemo Alone )

Also on site :

Most Viewed News
جديد الاخبار